First Yachting student fair brings 800 students to the Yacht Club de Monaco 23-03-2026, 20:31

Pioneering hospitals take major steps towards decarbonizing healthcare with Philips 3-10-2024, 16:15

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26